Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-21

Clinical Trial Update: Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing denosumab to zoledronic acid for osteoporotic compression fractures across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)
  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Denosumab vs Zoledronate | Phase 2, Phase 3 | Status: UNKNOWN